Prime Capital Investment Advisors, LLC Editas Medicine, Inc. Transaction History
Prime Capital Investment Advisors, LLC
- $7.33 Billion
- Q2 2025
A detailed history of Prime Capital Investment Advisors, LLC transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Prime Capital Investment Advisors, LLC holds 32,258 shares of EDIT stock, worth $71,290. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,258
Previous 47,846
32.58%
Holding current value
$71,290
Previous $55,000
27.27%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding EDIT
# of Institutions
223Shares Held
47.8MCall Options Held
436KPut Options Held
324K-
Black Rock Inc. New York, NY7.78MShares$17.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.16MShares$15.8 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.66MShares$5.88 Million0.0% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL2.6MShares$5.75 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.96MShares$4.34 Million0.0% of portfolio
About Editas Medicine, Inc.
- Ticker EDIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,737,200
- Market Cap $152M
- Description
- Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...